Pharmaceutical companies will no longer be able to block public comments on a Facebook wall. Because of strict regulations around that industry, where litigation lurks in every shadow, Facebook had
let drug companies nix comments and in some cases, disallow likes, bypassing the issue of having to respond to every complaint or censor unwanted posts.
That has now changed. Facebook
says the change was made to help encourage an authentic dialogue on pages. DailyTech says Pfizer has a Facebook page for patients suffering from hemophilia and MS, while Amgen and Sanofi plan to
maintain their Facebook pages despite the change in page Wall privacy.
Others, like Johnson & Johnson and AstraZenaca, have deleted or plan to delete their pages altogether. One of
AstraZenaca's sites, "Take on Depression," was reportedly closed Friday after receiving more than 1,100 likes.
advertisement
advertisement
Read the whole story at AllFacebook.com »